Please login to the form below

Not currently logged in

The PT Marketer of the Year competition due to close this Friday

Enter directly or nominate a colleague or team member

PT Marketer

Celebrating its 25th anniversary, the free-to-enter PharmaTimes Marketer of the Year Competition is closing for entries in just two days.

Designed to both assess and reward the competencies and potential of pharma marketers, the awards identifies and benchmarks marketing talent within pharma organisations against the wider industry.

Finalists are not judged on past work, but will be evaluated based on their performance during a head-to-head real life challenge against their peers.

Those who take part will receive qualitative and quantitative judges’ feedback.

Sabina Syed, managing director at Visions4Health and co-chair of the Marketer of the Year executive steering group, said: “This is the only competition that supports professional development and independently tests candidates on their marketing and communication skills against their peers across the industry.”

There are a total of six categories to choose from, including Market Access Lead of the Year, New Marketer of the Year, and new for 2018, the Aspiring Business Unit/Marketing Director.

Previous winner in the New Marketer of the Year Category Thom Renwick, Sales manager at Roche, said: “This type of experience not only helps you to benchmark but also allows you to network with some of the brightest minds in pharma.”

The programme accepts both nominations and direct entry and winners will be announced on Thursday 15 November at The Tower Hotel in London, alongside the PharmaTimes Sales Awards and Communications Team of the Year

Article by
Gemma Jones

11th September 2018

From: Marketing


Featured jobs

Subscribe to our email news alerts


Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...